Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
China · Delayed Price · Currency is CNY 15.25
-0.15 (-0.97%)
Sep 2, 2026, 3:04 PM CST
SHE:300653 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,736 | 3,547 | 3,798 | 5,224 | 7,740 | 8,012 | |
Market Cap Growth | -26.49% | -6.61% | -27.28% | -32.51% | -3.40% | 17.91% |
Enterprise Value | 2,118 | 2,935 | 3,189 | 4,604 | 7,152 | 7,493 |
Last Close Price | 15.40 | 19.63 | 20.45 | 26.89 | 39.20 | 39.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.42 | 43.05 | 28.21 | 27.36 | 41.74 | 47.54 |
Forward PE | 39.49 | 32.01 | 20.83 | 25.02 | 29.76 | 38.43 |
PS Ratio | 8.14 | 9.74 | 10.46 | 12.63 | 17.87 | 20.02 |
PB Ratio | 3.13 | 3.99 | 4.27 | 5.51 | 8.95 | 10.20 |
P/TBV Ratio | 3.24 | 4.13 | 4.44 | 5.72 | 9.35 | 10.72 |
P/FCF Ratio | 43.15 | 40.27 | 27.97 | 35.15 | 58.74 | 51.26 |
P/OCF Ratio | 35.16 | 36.50 | 25.09 | 28.94 | 41.21 | 48.23 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.30 | 8.06 | 8.78 | 11.13 | 16.51 | 18.72 |
EV/EBITDA Ratio | 26.68 | 30.87 | 21.37 | 21.80 | 33.23 | 41.02 |
EV/EBIT Ratio | 36.39 | 40.33 | 25.18 | 24.15 | 36.47 | 45.43 |
EV/FCF Ratio | 33.40 | 33.32 | 23.48 | 30.98 | 54.27 | 47.93 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Debt / Equity Ratio | -0.71 | -0.72 | -0.70 | -0.71 | -0.71 | -0.73 |
Net Debt / EBITDA Ratio | -7.78 | -6.70 | -4.17 | -3.20 | -2.86 | -3.13 |
Net Debt / FCF Ratio | -9.74 | -7.23 | -4.58 | -4.54 | -4.68 | -3.66 |
Asset Turnover | 0.35 | 0.37 | 0.36 | 0.41 | 0.45 | 0.46 |
Inventory Turnover | 1.58 | 1.59 | 1.25 | 1.11 | 1.34 | 1.54 |
Quick Ratio | 7.93 | 8.18 | 8.34 | 8.11 | 6.30 | 4.91 |
Current Ratio | 8.38 | 8.60 | 8.82 | 8.56 | 6.72 | 5.26 |
Return on Equity (ROE) | 8.06% | 9.27% | 14.66% | 21.06% | 22.47% | 23.54% |
Return on Assets (ROA) | 3.81% | 4.63% | 7.78% | 11.68% | 12.80% | 11.88% |
Return on Invested Capital (ROIC) | 21.73% | 26.23% | 41.49% | 63.97% | 74.22% | 69.84% |
Return on Capital Employed (ROCE) | 6.60% | 8.10% | 14.10% | 19.80% | 22.30% | 20.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.54% | 2.32% | 3.55% | 3.66% | 2.40% | 2.10% |
FCF Yield | 2.32% | 2.48% | 3.57% | 2.84% | 1.70% | 1.95% |
Dividend Yield | 1.86% | 1.43% | 2.25% | 2.98% | 1.53% | 1.47% |
Payout Ratio | 71.51% | 99.16% | 106.95% | 56.56% | 56.95% | 17.80% |
Buyback Yield / Dilution | 0.37% | 0.20% | 0.35% | -24.35% | 19.21% | -0.01% |
Total Shareholder Return | 2.23% | 1.63% | 2.60% | -21.37% | 20.74% | 1.46% |